You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.
ArmonAir Digihaler
ArmonAir Digihaler is an inhaled corticosteroid containing fluticasone propionate, designed for the maintenance treatment of asthma in adults and adolescents. It helps prevent asthma symptoms like wheezing, shortness of breath, and chest tightness by reducing inflammation in the airways. The Digihaler device is unique in that it includes built-in digital technology that records and tracks inhaler use, providing feedback to patients and healthcare providers to help manage asthma more effectively. ArmonAir Digihaler is part of the drug class known as inhaled corticosteroids (ICS), which are essential for long-term asthma management.
Drug Availability and Controlled Substance Status
ArmonAir Digihaler is available as a dry powder inhaler (DPI), providing a specific number of inhalations with different dosages, typically 55 mcg, 113 mcg, or 232 mcg per inhalation. This medication is not classified as a controlled substance, but it is available only by prescription. Patients should use ArmonAir Digihaler under the guidance of a healthcare provider to ensure proper dosing and effective management of asthma.
Oops! We currently don’t have the pricing information for this drug.
But we're continually improving our service to help you save and earn rebates on your medications. If your drug isn't listed on NiHowdy, you can still present your NiHowdy savings card at the pharmacy. We'll work to secure any eligible rebates for that drug and pass the savings back to you retroactively.
Members have saved
$NaN
using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!
NaNM
worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.
Frequently Asked Questions
How long does it take for ArmonAir Digihaler to start working?
ArmonAir Digihaler is designed for long-term control and prevention of asthma symptoms. While some improvement in symptoms may be noticed within the first week of use, it may take several weeks of regular use to achieve the full benefits of the medication.
Can ArmonAir Digihaler be used during an asthma attack?
No, ArmonAir Digihaler is not a rescue inhaler and should not be used to relieve an acute asthma attack. Patients should use a fast-acting bronchodilator, such as albuterol, during an asthma attack.
What should I do if I miss a dose of ArmonAir Digihaler?
If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to make up for the missed one.
Can children use ArmonAir Digihaler?
Yes, ArmonAir Digihaler is approved for use in children aged 12 years and older for the maintenance treatment of asthma. The dosage for children is typically lower than that for adults, and it is important to follow the healthcare provider’s instructions.
Is it safe to use ArmonAir Digihaler for a long time?
ArmonAir Digihaler is intended for long-term use to control asthma. However, long-term use of inhaled corticosteroids should be monitored by a healthcare provider to manage any potential side effects, such as bone thinning or increased risk of infections. Regular check-ups are recommended to ensure the medication is being used safely.
Comprehensive Drug Guide
How Does ArmonAir Digihaler Work?
ArmonAir Digihaler works by delivering fluticasone propionate directly to the lungs, where it reduces inflammation in the airways. This reduction in inflammation is crucial for preventing asthma symptoms, as it decreases swelling, irritation, and mucus production in the respiratory tract. By controlling inflammation, ArmonAir Digihaler helps improve overall lung function, making it easier to breathe and reducing the frequency and severity of asthma attacks.
Common Dosages
ArmonAir Digihaler is available in three strengths: 55 mcg, 113 mcg, and 232 mcg of fluticasone propionate per inhalation. The specific dosage prescribed will depend on the patient's age, severity of asthma, and response to the medication.
Typical Dosing
For adults and adolescents aged 12 years and older, the typical dosing of ArmonAir Digihaler is one inhalation twice daily (morning and evening). The initial dosage is often based on the severity of the asthma, with adjustments made over time to achieve optimal control. It is important for patients to follow their healthcare provider’s dosing instructions to ensure effective asthma management.
Typical Dosing
FDA Approved Indications
ArmonAir Digihaler is FDA-approved for the maintenance treatment of asthma in adults and children aged 12 years and older. It is intended for regular use to control and prevent asthma symptoms and is not suitable for use during an acute asthma attack. Off-label uses may include treatment for other inflammatory conditions of the airways, as advised by a healthcare provider.
Who Shouldn't Take ArmonAir Digihaler?
ArmonAir Digihaler should not be used in patients with a known hypersensitivity to fluticasone propionate or any other components of the inhaler. It is also contraindicated in patients experiencing acute asthma attacks, as it is not a fast-acting medication. Patients with untreated infections, such as tuberculosis or fungal infections of the lungs, should use ArmonAir Digihaler with caution.
Advice From The Pharmacist
Patients using ArmonAir Digihaler should be instructed on the proper inhaler technique to ensure the medication is delivered effectively to the lungs. It is important to rinse the mouth with water after each use to prevent oral thrush, a common side effect of inhaled corticosteroids. The Digihaler device should be kept dry and not washed, as moisture can affect its functionality. Patients should regularly check the digital display to track usage and ensure they are using the inhaler correctly. Regular follow-ups with a healthcare provider are recommended to monitor asthma control and adjust the treatment as necessary.
Side Effects of ArmonAir Digihaler
Common Side Effects
Common side effects of ArmonAir Digihaler include headache, sore throat, and hoarseness. Some patients may experience oral thrush, a fungal infection in the mouth, which can be minimized by rinsing the mouth after using the inhaler. Serious side effects, though rare, may include severe allergic reactions, vision problems, and adrenal suppression. Patients should seek immediate medical attention if they experience symptoms of a severe allergic reaction, such as difficulty breathing or swelling of the face, lips, or throat.
Risks and Warnings of ArmonAir Digihaler
ArmonAir Digihaler may suppress the immune system, increasing the risk of infections such as oral thrush or respiratory infections. Long-term use of corticosteroids can lead to bone thinning (osteoporosis), cataracts, and glaucoma, especially if used at high doses. Regular monitoring by a healthcare provider is essential to minimize these risks and ensure that the medication is being used safely and effectively.
Interactions with ArmonAir Digihaler
Common Drug Interactions
ArmonAir Digihaler may interact with other corticosteroids or medications that suppress the immune system, increasing the risk of side effects. It may also interact with medications that affect liver enzymes, such as certain antifungal drugs (e.g., ketoconazole) or HIV protease inhibitors, potentially altering the levels of fluticasone in the body. Patients should inform their healthcare provider of all medications and supplements they are taking to avoid potential interactions.
Alternatives to ArmonAir Digihaler
Alternative treatments to ArmonAir Digihaler include other inhaled corticosteroids such as fluticasone (Flovent) or budesonide (Pulmicort). Combination inhalers that include both a corticosteroid and a long-acting beta agonist (LABA), such as Advair (fluticasone/salmeterol) or Symbicort (budesonide/formoterol), may also be considered for patients who require additional control of their asthma symptoms. The choice of alternative treatment will depend on the patient’s specific condition and response to previous therapies.
